BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23534718)

  • 1. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma.
    Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2013; 14(1):165-71. PubMed ID: 23534718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
    Guler G; Huebner K; Himmetoglu C; Jimenez RE; Costinean S; Volinia S; Pilarski RT; Hayran M; Shapiro CL
    Cancer; 2009 Feb; 115(4):899-908. PubMed ID: 19130459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma.
    Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A
    Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between FHIT and WWOX expression and clinicopathological features in hepatocellular carcinoma].
    Lin J; Wang B; Huang AM; Wang XJ
    Zhonghua Gan Zang Bing Za Zhi; 2010 May; 18(5):357-60. PubMed ID: 20510001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.
    Bloomston M; Kneile J; Butterfield M; Dillhoff M; Muscarella P; Ellison EC; Melvin WS; Croce CM; Pichiorri F; Huebner K; Frankel WL
    Ann Surg Oncol; 2009 Aug; 16(8):2331-8. PubMed ID: 19434452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of FHIT and WWOX expression in mucoepidermoid carcinoma and adenoid cystic carcinoma of salivary gland.
    Dincer N; Tezel GG; Sungur A; Himmetoglu C; Huebner K; Güler G
    Oral Oncol; 2010 Mar; 46(3):195-9. PubMed ID: 20060354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordant loss of fragile gene expression early in breast cancer development.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
    Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic imbalance and abnormal expression of FHIT in endemic nasopharyngeal carcinoma: association with clinicopathological features.
    Deng YF; Zhou DN; Lu YD
    Eur Arch Otorhinolaryngol; 2010 Dec; 267(12):1933-41. PubMed ID: 20552362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhit and Wwox loss-associated genome instability: A genome caretaker one-two punch.
    Schrock MS; Karras JR; Guggenbiller MJ; Druck T; Batar B; Huebner K
    Adv Biol Regul; 2017 Jan; 63():167-176. PubMed ID: 27773744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of WWOX and FHIT is downregulated by exposure to arsenite in human uroepithelial cells.
    Huang YC; Hung WC; Chen WT; Yu HS; Chai CY
    Toxicol Lett; 2013 Jul; 220(2):118-25. PubMed ID: 23618899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
    Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
    Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-214 Mediates Cell Proliferation and Apoptosis of Nasopharyngeal Carcinoma Through Targeting Both WWOX and PTEN.
    Han JB; Huang ML; Li F; Yang R; Chen SM; Tao ZZ
    Cancer Biother Radiopharm; 2020 Oct; 35(8):615-625. PubMed ID: 32101017
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss expression of active fragile sites genes associated with the severity of breast epithelial abnormalities.
    Wang TT; Frezza EE; Ma R; Hu SY; Liu CZ; Zhang GY; Wachtel MS; Lü XM; Feng JB; Lü CX
    Chin Med J (Engl); 2008 Oct; 121(20):1969-74. PubMed ID: 19080258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of WWOX in the development of esophageal squamous cell carcinoma.
    Guo W; Wang G; Dong Y; Guo Y; Kuang G; Dong Z
    Mol Carcinog; 2013 Apr; 52(4):265-74. PubMed ID: 22213016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.